drugset / Trial / NCT02504801
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
RandomizedParallel-groupSingle-blindPrevention
Summary
To test the hypothesis that nebulized Pulmicort Respules could reduce post operation pulmonary complication incidence in primary lung cancer patients with COPD. Compare post-operation pulmonary complication incidence in two treatment arms among primary lung cancer patients with COPD required single lobectomy from 3days before operation to 7 days after operation.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-07
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 2 mg | Other |